Exploring potential of diacerin nanogel for topical application in arthritis: Formulation development, QbD based optimization and pre-clinical evaluation

Diacerein (DCN) is a chondroprotective agent which shows inadequate oral bioavailability along with gastrointestinal side effects. This study is intended to develop a topical novel DCN delivery system. DCN nanogel was prepared by emulsion solvent diffusion technique. The formulation was optimized by...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Colloids and surfaces, B, Biointerfaces B, Biointerfaces, 2023-03, Vol.223, p.113160-113160, Article 113160
Hauptverfasser: Kesharwani, Disha, Das Paul, Swarnali, Paliwal, Rishi, Satapathy, Trilochan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 113160
container_issue
container_start_page 113160
container_title Colloids and surfaces, B, Biointerfaces
container_volume 223
creator Kesharwani, Disha
Das Paul, Swarnali
Paliwal, Rishi
Satapathy, Trilochan
description Diacerein (DCN) is a chondroprotective agent which shows inadequate oral bioavailability along with gastrointestinal side effects. This study is intended to develop a topical novel DCN delivery system. DCN nanogel was prepared by emulsion solvent diffusion technique. The formulation was optimized by response surface methodology by taking two independent variables, concentration of carbopol 940 and eudragit RSPO and three dependent variables, particle size, % entrapment efficiency (EE) and % drug release at 24 h. The optimized formulation had adequat% EE, % drug release at 24 h and particle size. The particle size for optimized nanogel was 190.3 nm with % EE of 83.51% whereas % drug release at 24 h was found 90.13%. The optimized DCN nanogel was analyzed by differential scanning calorimetry (DSC), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (DTIR) and transmission electron microscopy (TEM) studies. The drug release kinetic study has shown that the gel followed Higuchi’s model and the diffusion was anomalous in nature. The nanogel was characterized for physical examination, viscosity, homogeneity and stability parameters and the results obtained were found upto the mark. The ex-vivo permeation study data was in correlation with results of in-vitro study. In-vivo anti-arthritic study proved the efficacy of developed formulation for arthritis in Freund’s Adjuvant Arthritic model. This research work has proved the significant potential of innovated product for arthritis by topical route, as it overcomes the drawbacks of oral route, highly efficient, sustained and targeted the release of drug without any accumulation and toxicity. [Display omitted] •A novel diacerin loaded nanogel formulation was developed and optimized using quality by design approach.•The target product profile of diacerin nanogel was successfully achieved and model was validated.•The formulation was stable upon storage and has shown desired drug release profile and drug permeation ex vivo.•Animal studied confirmed anti-arthritic potential of diacerin loaded nanogel upon topical application.
doi_str_mv 10.1016/j.colsurfb.2023.113160
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2773125878</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0927776523000383</els_id><sourcerecordid>2773125878</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-6b082c21460896e31c970510e9f8e38b4b956531417b58313b1eb2d99c33c9bf3</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi0EotvCK1Q-ciCLHW9shxOotFCpUlUJzpbtTIpXTmxsZwW8CW9bt2l75TSj-b_5R6MfoVNKtpRQ_mG_tcHnJY1m25KWbSlllJMXaEOlYM2OcfESbUjfikYI3h2h45z3hJB2R8VrdFRlxqnoNujf-e_oQ3LzLY6hwFyc9jiMeHDaQh3jWc_hFjweQ8IlRGerrmP0tSkuzLgiOpWfyRWXP-KLkKbFr8oAB_AhTtX0Pb4xX7DRGQYcYnGT-7syeh5wTNBY7-YHazhovzxob9CrUfsMbx_rCfpxcf797Ftzdf318uzzVWMZl6XhhsjWtnTHiew5MGp7QTpKoB8lMGl2pu94x2h93HSSUWYomHboe8uY7c3ITtC71Tem8GuBXNTksgXv9QxhyaoVgtG2k0JWlK-oTSHnBKOKyU06_VGUqPtY1F49xaLuY1FrLHXx9PHGYiYYnteecqjApxWA-unBQVLZOpgtDC6BLWoI7n837gA2Y6TE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2773125878</pqid></control><display><type>article</type><title>Exploring potential of diacerin nanogel for topical application in arthritis: Formulation development, QbD based optimization and pre-clinical evaluation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Kesharwani, Disha ; Das Paul, Swarnali ; Paliwal, Rishi ; Satapathy, Trilochan</creator><creatorcontrib>Kesharwani, Disha ; Das Paul, Swarnali ; Paliwal, Rishi ; Satapathy, Trilochan</creatorcontrib><description>Diacerein (DCN) is a chondroprotective agent which shows inadequate oral bioavailability along with gastrointestinal side effects. This study is intended to develop a topical novel DCN delivery system. DCN nanogel was prepared by emulsion solvent diffusion technique. The formulation was optimized by response surface methodology by taking two independent variables, concentration of carbopol 940 and eudragit RSPO and three dependent variables, particle size, % entrapment efficiency (EE) and % drug release at 24 h. The optimized formulation had adequat% EE, % drug release at 24 h and particle size. The particle size for optimized nanogel was 190.3 nm with % EE of 83.51% whereas % drug release at 24 h was found 90.13%. The optimized DCN nanogel was analyzed by differential scanning calorimetry (DSC), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (DTIR) and transmission electron microscopy (TEM) studies. The drug release kinetic study has shown that the gel followed Higuchi’s model and the diffusion was anomalous in nature. The nanogel was characterized for physical examination, viscosity, homogeneity and stability parameters and the results obtained were found upto the mark. The ex-vivo permeation study data was in correlation with results of in-vitro study. In-vivo anti-arthritic study proved the efficacy of developed formulation for arthritis in Freund’s Adjuvant Arthritic model. This research work has proved the significant potential of innovated product for arthritis by topical route, as it overcomes the drawbacks of oral route, highly efficient, sustained and targeted the release of drug without any accumulation and toxicity. [Display omitted] •A novel diacerin loaded nanogel formulation was developed and optimized using quality by design approach.•The target product profile of diacerin nanogel was successfully achieved and model was validated.•The formulation was stable upon storage and has shown desired drug release profile and drug permeation ex vivo.•Animal studied confirmed anti-arthritic potential of diacerin loaded nanogel upon topical application.</description><identifier>ISSN: 0927-7765</identifier><identifier>EISSN: 1873-4367</identifier><identifier>DOI: 10.1016/j.colsurfb.2023.113160</identifier><identifier>PMID: 36736175</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Administration, Topical ; Arthritis ; Bioavailability ; Diacerein ; Drug Carriers - chemistry ; Nanogel ; Nanogels ; Particle Size ; Polyethylene Glycols - chemistry ; QbD ; Topical</subject><ispartof>Colloids and surfaces, B, Biointerfaces, 2023-03, Vol.223, p.113160-113160, Article 113160</ispartof><rights>2023 Elsevier B.V.</rights><rights>Copyright © 2023 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-6b082c21460896e31c970510e9f8e38b4b956531417b58313b1eb2d99c33c9bf3</citedby><cites>FETCH-LOGICAL-c368t-6b082c21460896e31c970510e9f8e38b4b956531417b58313b1eb2d99c33c9bf3</cites><orcidid>0000-0002-7549-707X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.colsurfb.2023.113160$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36736175$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kesharwani, Disha</creatorcontrib><creatorcontrib>Das Paul, Swarnali</creatorcontrib><creatorcontrib>Paliwal, Rishi</creatorcontrib><creatorcontrib>Satapathy, Trilochan</creatorcontrib><title>Exploring potential of diacerin nanogel for topical application in arthritis: Formulation development, QbD based optimization and pre-clinical evaluation</title><title>Colloids and surfaces, B, Biointerfaces</title><addtitle>Colloids Surf B Biointerfaces</addtitle><description>Diacerein (DCN) is a chondroprotective agent which shows inadequate oral bioavailability along with gastrointestinal side effects. This study is intended to develop a topical novel DCN delivery system. DCN nanogel was prepared by emulsion solvent diffusion technique. The formulation was optimized by response surface methodology by taking two independent variables, concentration of carbopol 940 and eudragit RSPO and three dependent variables, particle size, % entrapment efficiency (EE) and % drug release at 24 h. The optimized formulation had adequat% EE, % drug release at 24 h and particle size. The particle size for optimized nanogel was 190.3 nm with % EE of 83.51% whereas % drug release at 24 h was found 90.13%. The optimized DCN nanogel was analyzed by differential scanning calorimetry (DSC), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (DTIR) and transmission electron microscopy (TEM) studies. The drug release kinetic study has shown that the gel followed Higuchi’s model and the diffusion was anomalous in nature. The nanogel was characterized for physical examination, viscosity, homogeneity and stability parameters and the results obtained were found upto the mark. The ex-vivo permeation study data was in correlation with results of in-vitro study. In-vivo anti-arthritic study proved the efficacy of developed formulation for arthritis in Freund’s Adjuvant Arthritic model. This research work has proved the significant potential of innovated product for arthritis by topical route, as it overcomes the drawbacks of oral route, highly efficient, sustained and targeted the release of drug without any accumulation and toxicity. [Display omitted] •A novel diacerin loaded nanogel formulation was developed and optimized using quality by design approach.•The target product profile of diacerin nanogel was successfully achieved and model was validated.•The formulation was stable upon storage and has shown desired drug release profile and drug permeation ex vivo.•Animal studied confirmed anti-arthritic potential of diacerin loaded nanogel upon topical application.</description><subject>Administration, Topical</subject><subject>Arthritis</subject><subject>Bioavailability</subject><subject>Diacerein</subject><subject>Drug Carriers - chemistry</subject><subject>Nanogel</subject><subject>Nanogels</subject><subject>Particle Size</subject><subject>Polyethylene Glycols - chemistry</subject><subject>QbD</subject><subject>Topical</subject><issn>0927-7765</issn><issn>1873-4367</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhi0EotvCK1Q-ciCLHW9shxOotFCpUlUJzpbtTIpXTmxsZwW8CW9bt2l75TSj-b_5R6MfoVNKtpRQ_mG_tcHnJY1m25KWbSlllJMXaEOlYM2OcfESbUjfikYI3h2h45z3hJB2R8VrdFRlxqnoNujf-e_oQ3LzLY6hwFyc9jiMeHDaQh3jWc_hFjweQ8IlRGerrmP0tSkuzLgiOpWfyRWXP-KLkKbFr8oAB_AhTtX0Pb4xX7DRGQYcYnGT-7syeh5wTNBY7-YHazhovzxob9CrUfsMbx_rCfpxcf797Ftzdf318uzzVWMZl6XhhsjWtnTHiew5MGp7QTpKoB8lMGl2pu94x2h93HSSUWYomHboe8uY7c3ITtC71Tem8GuBXNTksgXv9QxhyaoVgtG2k0JWlK-oTSHnBKOKyU06_VGUqPtY1F49xaLuY1FrLHXx9PHGYiYYnteecqjApxWA-unBQVLZOpgtDC6BLWoI7n837gA2Y6TE</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Kesharwani, Disha</creator><creator>Das Paul, Swarnali</creator><creator>Paliwal, Rishi</creator><creator>Satapathy, Trilochan</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7549-707X</orcidid></search><sort><creationdate>202303</creationdate><title>Exploring potential of diacerin nanogel for topical application in arthritis: Formulation development, QbD based optimization and pre-clinical evaluation</title><author>Kesharwani, Disha ; Das Paul, Swarnali ; Paliwal, Rishi ; Satapathy, Trilochan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-6b082c21460896e31c970510e9f8e38b4b956531417b58313b1eb2d99c33c9bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Administration, Topical</topic><topic>Arthritis</topic><topic>Bioavailability</topic><topic>Diacerein</topic><topic>Drug Carriers - chemistry</topic><topic>Nanogel</topic><topic>Nanogels</topic><topic>Particle Size</topic><topic>Polyethylene Glycols - chemistry</topic><topic>QbD</topic><topic>Topical</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kesharwani, Disha</creatorcontrib><creatorcontrib>Das Paul, Swarnali</creatorcontrib><creatorcontrib>Paliwal, Rishi</creatorcontrib><creatorcontrib>Satapathy, Trilochan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Colloids and surfaces, B, Biointerfaces</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kesharwani, Disha</au><au>Das Paul, Swarnali</au><au>Paliwal, Rishi</au><au>Satapathy, Trilochan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exploring potential of diacerin nanogel for topical application in arthritis: Formulation development, QbD based optimization and pre-clinical evaluation</atitle><jtitle>Colloids and surfaces, B, Biointerfaces</jtitle><addtitle>Colloids Surf B Biointerfaces</addtitle><date>2023-03</date><risdate>2023</risdate><volume>223</volume><spage>113160</spage><epage>113160</epage><pages>113160-113160</pages><artnum>113160</artnum><issn>0927-7765</issn><eissn>1873-4367</eissn><abstract>Diacerein (DCN) is a chondroprotective agent which shows inadequate oral bioavailability along with gastrointestinal side effects. This study is intended to develop a topical novel DCN delivery system. DCN nanogel was prepared by emulsion solvent diffusion technique. The formulation was optimized by response surface methodology by taking two independent variables, concentration of carbopol 940 and eudragit RSPO and three dependent variables, particle size, % entrapment efficiency (EE) and % drug release at 24 h. The optimized formulation had adequat% EE, % drug release at 24 h and particle size. The particle size for optimized nanogel was 190.3 nm with % EE of 83.51% whereas % drug release at 24 h was found 90.13%. The optimized DCN nanogel was analyzed by differential scanning calorimetry (DSC), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (DTIR) and transmission electron microscopy (TEM) studies. The drug release kinetic study has shown that the gel followed Higuchi’s model and the diffusion was anomalous in nature. The nanogel was characterized for physical examination, viscosity, homogeneity and stability parameters and the results obtained were found upto the mark. The ex-vivo permeation study data was in correlation with results of in-vitro study. In-vivo anti-arthritic study proved the efficacy of developed formulation for arthritis in Freund’s Adjuvant Arthritic model. This research work has proved the significant potential of innovated product for arthritis by topical route, as it overcomes the drawbacks of oral route, highly efficient, sustained and targeted the release of drug without any accumulation and toxicity. [Display omitted] •A novel diacerin loaded nanogel formulation was developed and optimized using quality by design approach.•The target product profile of diacerin nanogel was successfully achieved and model was validated.•The formulation was stable upon storage and has shown desired drug release profile and drug permeation ex vivo.•Animal studied confirmed anti-arthritic potential of diacerin loaded nanogel upon topical application.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>36736175</pmid><doi>10.1016/j.colsurfb.2023.113160</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-7549-707X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0927-7765
ispartof Colloids and surfaces, B, Biointerfaces, 2023-03, Vol.223, p.113160-113160, Article 113160
issn 0927-7765
1873-4367
language eng
recordid cdi_proquest_miscellaneous_2773125878
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Administration, Topical
Arthritis
Bioavailability
Diacerein
Drug Carriers - chemistry
Nanogel
Nanogels
Particle Size
Polyethylene Glycols - chemistry
QbD
Topical
title Exploring potential of diacerin nanogel for topical application in arthritis: Formulation development, QbD based optimization and pre-clinical evaluation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A22%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exploring%20potential%20of%20diacerin%20nanogel%20for%20topical%20application%20in%20arthritis:%20Formulation%20development,%20QbD%20based%20optimization%20and%20pre-clinical%20evaluation&rft.jtitle=Colloids%20and%20surfaces,%20B,%20Biointerfaces&rft.au=Kesharwani,%20Disha&rft.date=2023-03&rft.volume=223&rft.spage=113160&rft.epage=113160&rft.pages=113160-113160&rft.artnum=113160&rft.issn=0927-7765&rft.eissn=1873-4367&rft_id=info:doi/10.1016/j.colsurfb.2023.113160&rft_dat=%3Cproquest_cross%3E2773125878%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2773125878&rft_id=info:pmid/36736175&rft_els_id=S0927776523000383&rfr_iscdi=true